B. Pizzo

发表

Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma

M. Kris, V. Miller, L. Krug, 2000, Cancer.

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.

M. Kris, V. Miller, L. Krug, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin

M. Kris, V. Miller, L. Krug, 2004, Clinical Cancer Research.

An Explanation for the Increasing Incidence of Testis Cancer : Decreasing Age at First Full-Term Pregnancy

M. Kris, P. Hesketh, B. Pizzo, 1997 .

APhase 1 Study of Pralatrexate in Combinationwith Paclitaxel or Docetaxel in Patients with Advanced SolidTumors

M. Kris, C. Azzoli, E. Venkatraman, 2007 .

A Phase 1 Study of Pralatrexate in Combination with Paclitaxel or Docetaxel in Patients with Advanced Solid Tumors

M. Kris, C. Azzoli, E. Venkatraman, 2007, Clinical Cancer Research.

Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer.

M. Kris, V. Miller, L. Krug, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevention of acute emesis in cancer patients following high-dose cisplatin with the combination of oral dolasetron and dexamethasone.

M. Kris, R. Navari, B. Ferguson, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.

M. Kris, V. Miller, K. Ng, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin.

M. Kris, P. Hesketh, B. Pizzo, 1997, Journal of the National Cancer Institute.

A Phase II Tolerability Study of Cisplatin Plus Docetaxel as Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer

C. Rudin, M. Kris, C. Azzoli, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

New directions in oncology nursing care: focus on gefitinib in patients with lung cancer.

B. Pizzo, 2004, Clinical journal of oncology nursing.

A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors

M. Kris, C. Azzoli, N. Rosen, 2007, Cancer Chemotherapy and Pharmacology.

Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.

M. Kris, M. J. Nolte, R. Berkery, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral cisapride for the control of delayed vomiting following high-dose cisplatin

M. Kris, V. Miller, K. Pisters, 1999, Supportive Care in Cancer.

C-kit protein expression in tumor specimens as a predictor of sensitivity to imatinib mesylate in patients with small cell lung cancer (SCLC): A phase II clinical trial.

M. Kris, C. Azzoli, J. Crapanzano, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.